The current Ebola emergency in the Democratic Republic of the Congo is caused by Bundibugyo virus, a distinct ebolavirus species for which no vaccine has been licensed. On 1 November, the Associated Press reported the latest Congolese health-ministry figures at 10,351 confirmed cases and 5,026 deaths. The numbers are devastating, but they need to be read with their reporting dates attached: international agencies are still reviewing and harmonising the data, while the response is trying to reach communities before people become critically ill.

The latest numbers are serious—and their cut-off dates matter

The Associated Press reported on 1 November that the latest figures from the DRC Ministry of Health showed 10,351 confirmed cases and 5,026 deaths. The ECDC, using data through 27 October in its 29 October update, reported 10,193 confirmed cases and 4,960 related deaths. WHO's 23 October bulletin had recorded 9,704 cases and 4,687 deaths as of 20 October. These are successive snapshots, not competing totals with the same cut-off date.

ECDC notes that Congolese data remain under review and harmonisation. WHO said 307 of the 482 deaths reported in the period before its 20 October snapshot had occurred in communities rather than treatment centres. A reported case-fatality ratio therefore reflects not only the virus, but also late detection, access to care and deaths that occur before a patient reaches a treatment centre.

The U.S. Centers for Disease Control and Prevention's 30 October update listed 10,274 confirmed cases and 4,992 confirmed deaths in the DRC as of 28 October. That snapshot is not identical to the later Ministry of Health figures reported by AP on 1 November. The dates and data-standardisation methods differ, so the totals should be presented as separate dated snapshots rather than combined or treated as evidence that cases fell.

Sources: Ebola outbreak in Congo tops 5,000 deaths as health workers struggle to contain it · Ebola disease outbreak caused by Bundibugyo virus – Multi-country – 2026 · Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo, Kenya and Nigeria · Ebola Outbreak: Current Situation

Bundibugyo is not the Ebola strain covered by the existing licensed vaccine

The outbreak is caused by Bundibugyo virus (BDBV), not Zaire ebolavirus (EBOV). Ervebo is licensed for disease caused by Zaire ebolavirus, not Bundibugyo. WHO says there is not enough human evidence to establish that Ervebo protects against Bundibugyo and recommends its use in this outbreak only within a research protocol. ECDC also reports no approved vaccine or specific therapeutic for Bundibugyo virus.

The DRC began a vaccination campaign for frontline workers in some affected provinces on 27 August under that research framework. The TUMAINI Phase 2/3 trial began vaccinating its first participant in Bunia on 23 October, with Ervebo as its first candidate; two Bundibugyo-specific candidates from Moderna and Oxford/Serum Institute were being prepared for later entry. A trial and a research-protocol campaign are not the same as a licensed, proven vaccine.

Sources: Ebola disease outbreak caused by Bundibugyo virus – Multi-country – 2026 · First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC · Ebola vaccines: questions and answers · WHO interim guidance on use of Ebola vaccine in Bundibugyo virus disease outbreaks

The hardest part may be reaching people before they are critically ill

WHO's October situation report highlighted how many deaths were occurring outside formal treatment centres. AP's 1 November reporting also described a large share of recent infections appearing outside monitored contact chains. When people are diagnosed late, or their contacts cannot be identified and followed, the response loses time essential for isolation, supportive care and preventing further transmission.

The response is also taking place amid insecurity, mistrust and pressure on health services. AP reported health workers describing unpaid wages and interruptions at some facilities, alongside risks from armed groups and attacks on response personnel. Staffing, safe access, community trust and reliable pay are part of outbreak control, not administrative details separate from it.

Sources: Ebola outbreak in Congo tops 5,000 deaths as health workers struggle to contain it · Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo, Kenya and Nigeria

Cross-border cases need careful reading

WHO's 23 October bulletin described imported cases in Kenya and Nigeria. ECDC's 29 October update recorded nine confirmed cases and two deaths in Kenya by 26 October, linked to the initial travel-related infection. Nigeria reported one confirmed imported Bundibugyo case on 20 October; the patient was medically evacuated to Switzerland on 26 October, and 62 contacts were being followed up as of 27 October. Uganda's earlier outbreak was declared over on 27 August after 42 days without a new confirmed case.

Nigeria's later alerts show why suspected cases must not be turned into confirmed ones. The Nigeria Centre for Disease Control's official channel said two people identified in Yola, Adamawa State, tested negative for Ebola after two rounds of laboratory testing; the previously confirmed Federal Capital Territory case remained the country's only confirmed infection.

Sources: Ebola disease outbreak caused by Bundibugyo virus – Multi-country – 2026 · Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo, Kenya and Nigeria · Official channel update: two suspected Adamawa cases test negative after two rounds of testing · Ebola Disease Situation Report, 29 October 2026

What meaningful progress would look like

The U.S. Centers for Disease Control and Prevention says no cases associated with this outbreak have been reported in the United States and assesses the likelihood of spread to the U.S. as very low. ECDC's assessment is similarly focused on the affected areas and management of imported cases. These assessments distinguish a major regional emergency from a generalised risk to people everywhere.

The clearest signs of improvement would be sustained declines in newly confirmed cases, faster detection, more complete contact follow-up, fewer deaths in communities before people reach care, and safe access for health workers. Vaccine research matters, but it cannot replace case finding, supportive care, infection prevention, community engagement and protection for response workers.

Sources: Ebola outbreak in Congo tops 5,000 deaths as health workers struggle to contain it · Ebola disease outbreak caused by Bundibugyo virus – Multi-country – 2026 · Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo, Kenya and Nigeria · First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC · Ebola Outbreak: Current Situation